← Leaderboards
John Louis Joyal
Molecular Insight Pharmaceuticals, Inc.
$684,947
Attributed
$684,947
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $204.4K · FY2008–11$250K$187.5K$125K$62.5K$0
'08
'09
'10
'11
Funding mix
By agency
NIH$684,947 · 3
By mechanism
R43$385,267 · 2
R21$299,680 · 1
Top collaborators
No co-investigators on record.
Most similar at Molecular Insight Pharmaceuticals, Inc.
Same institution · by research overlap
- James F Kronauge$10,765,400
- Jon A Zubieta$379,336
- Kevin P Maresca$402,626
Others in their field
Top investigators on “Label”
- Hongkui Zeng · Allen Institute$97,148,216
- Asimah Rafi · Technical Resources Inc$95,881,052
- Mine Cicek · Mayo Clinic Rochester$80,721,262
- Stephen Norman Thibodeau · Mayo Clinic Rochester$70,778,831
- David Heimbrook · Leidos Biomedical Research, Inc.$64,944,535
- Oscar R Benavente · University Of Texas Hlth Sci Ctr San Ant$62,998,325
Research focus
LabelMalignant NeoplasmsInhibitor/AntagonistIn VivoExhibitsLeadDesignImaging TechniquesDiagnosticIn VitroEnzymesAffinityCellular AssayEvaluationBaseBinding (Molecular Function)BiochemicalImageCellsDiagnosisDrug KineticsDiscipline Of Nuclear MedicineAnalogMolecular Imaging
Grant awards (4)
Targeting Tumor Hypoxia with Radiohalogenated Inhibitors of Carbonic Anhydrase IX$188,585
R21 · FY2011 · CA · contact PI
Targeting Tumor Hypoxia with Radiohalogenated Inhibitors of Carbonic Anhydrase IX$111,095
R21 · FY2010 · CA · contact PI
Targeting Tumor Microenvironment with Radiolabeled Inhibitors of Seprase (FAPalph$180,916
R43 · FY2009 · CA · contact PI
Radiolabeled Inhibitors of Carbonic Anhydrase IX$204,351
R43 · FY2008 · CA · contact PI